Biphasic modulation of apoptotic pathways in Cryptosporidium parvum-infected human intestinal epithelial cells.
The impact of Cryptosporidium parvum infection on host cell gene expression was investigated by microarray analysis with an in vitro model using human ileocecal HCT-8 adenocarcinoma cells. We found changes in 333 (2.6%) transcripts at at least two of the five (6, 12, 24, 48, and 72 h) postinfection time points. Fifty-one of the regulated genes were associated with apoptosis and were grouped into five clusters based on their expression patterns. Early in infection (6 and 12 h), genes with antiapoptotic roles were upregulated and genes with apoptotic roles were downregulated. Later in infection (24, 48, and 72 h), proapoptotic genes were induced and antiapoptotic genes were downregulated, suggesting a biphasic regulation of apoptosis: antiapoptotic state early and moderately proapoptotic state late in infection. This transcriptional profile matched the actual occurrence of apoptosis in the infected cultures. Apoptosis was first detected at 12 h postinfection and increased to a plateau at 24 h, when 20% of infected cells showed nuclear condensation. In contrast, experimental silencing of Bcl-2 induced apoptosis in 50% of infected cells at 12 h postinfection. This resulted in a decrease in the infection rate and a reduction in the accumulation of meront-containing cells. To test the significance of the moderately proapoptotic state late in the infection, we inhibited apoptosis using pancaspase inhibitor Z-VAD-FMK. This treatment also affected the progression of C. parvum infection, as reinfection, normally seen late (24 h to 48 h), did not occur and accumulation of mature meronts was impaired. Control of host apoptosis is complex and crucial to the life of C. parvum. Apoptosis control has at least two components, early inhibition and late moderate promotion. For a successful infection, both aspects appear to be required.
Liu
Jin
J
Department of Veterinary and Biomedical Sciences, University of Minnesota, 1988 Fitch Ave., No. 295, St. Paul, MN 55108, USA.
Deng
Mingqi
M
Lancto
Cheryl A
CA
Abrahamsen
Mitchell S
MS
Rutherford
Mark S
MS
Enomoto
Shinichiro
S
D000818:Animals; D017209:Apoptosis / Q000502:physiology*; D061945:Caspase Inhibitors; D045744:Cell Line, Tumor; D016785:Cryptosporidium parvum / Q000502:physiology*; D004847:Epithelial Cells / Q000378:metabolism* / Q000469:parasitology*; D020869:Gene Expression Profiling; D005786:Gene Expression Regulation / Q000502:physiology*; D020868:Gene Silencing; D019254:Genes, bcl-2; D006801:Humans; D007413:Intestinal Mucosa / Q000166:cytology; D013997:Time Factors
D061945:Caspase Inhibitors